Showing results (31-40 of 51) with videos related to
Sort By:
Pageof 6
Journal of Hazardous Materials|December 9, 2021
Continuous electron shuttling by sulfide oxidizing bacteria as a novel strategy to produce electric currentRieks de Rink, Micaela B Lavender, Dandan Liu, et al.Water Research|November 27, 2012
A physiologically based kinetic model for bacterial sulfide oxidationJohannes B M Klok, Marco de Graaff, Pim L F van den Bosch, et al.Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Pharmacoeconomics of quetiapine for the management of acute mania in bipolar I disorderRogier M Klok, Asmar Fy Al Hadithy, Nathalie Pjt van Schayk, et al.Clinical Therapeutics|December 7, 2005
Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care settingRogier M Klok, Nicolaas L A Arents, Robin de Vries, et al.Journal of Hazardous Materials|October 7, 2019
Biologically enhanced hydrogen sulfide absorption from sour gas under haloalkaline conditionsRieks de Rink, Johannes B M Klok, Gijs J van Heeringen, et al.Environmental Science & Technology|June 16, 2012
Pathways of sulfide oxidation by haloalkaliphilic bacteria in limited-oxygen gas lift bioreactorsJohannes B M Klok, Pim L F van den Bosch, Cees J N Buisman, et al.Helicobacter|May 26, 2004
Pharmacoeconomics of gastrointestinal drug utilisation prior and post Helicobacter pylori eradicationRogier M Klok, Willem Jan van der Veen, Ger Th van der Werf, et al.Arthritis Research & Therapy|December 17, 2008
Incremental cost effectiveness of proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug ulcers: a pharmacoeconomic analysis linked to a case-control studyHarald E Vonkeman, Louise M A Braakman-Jansen, Rogier M Klok, et al.Journal of Cancer Survivorship : Research and Practice|September 3, 2024
Experienced financial toxicity among long-term cancer survivors: results from a national cross-sectional surveyJente M Klok, Saskia F A Duijts, Vivian Engelen, et al.Applied Health Economics and Health Policy|November 29, 2005
Drug costs developments after patent expiry of enalapril, fluoxetine and ranitidine: a study conducted for the NetherlandsCornelis Boersma, Rogier M Klok, Jasper M Bos, et al.Pageof 6